Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624's novel epigenetic mechanism of action on neurological pathways. The findings provide ...

Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624's novel epigenetic mechanism of action on neurological pathways. The findings provide ...

Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

Comedian and actress Aida Rodriguez pens a personal essay where she shares how getting diagnosed with ADHD changed her life ...

A University of Alberta research team has successfully used machine learning as a tool for earlier detection of attention ...

A study of older adults showed that 6% had depression, with higher prevalences in certain groups, including women, those who ...

Many medications that are commonly referred to as “weight loss drugs” are not actually FDA-approved for this purpose. One of the most popular—Ozempic—is a type 2 diabetes drug that’s often prescribed ...

Attention deficit hyperactivity disorder symptoms worsen right before and during a period, a new study finds, and this could ...

Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use ...

Treating ADHD is straightforward with stimulants, often giving patients life-changing relief. But with comorbid conditions, ...